Clinical Trials Directory

Trials / Completed

CompletedNCT02625103

The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring.

The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
48 (actual)
Sponsor
Anders Fink-Jensen, MD, DMSci · Academic / Other
Sex
All
Age
18 Years – 64 Years
Healthy volunteers
Not accepted

Summary

The role of Therapeutic Drug Monitoring (TDM) in clozapine dose adjustment have been debated. Blood samples for s-clozapine monitoring should be drawn 12 hours post dose. The scope of this trial is to describe changes of s-clozapine and s-N-desmethyl-clozapine within the range of 10-14 hours after the last administration of clozapine .

Detailed description

Several factors can influence s-clozapine and thereby the occurence of dose-related adverse reactions and level of treatment response. The role of Therapeutic Drug Monitoring (TDM) in clozapine dose adjustment have been debated. Blood samples for s-clozapine monitoring are recommended to be drawn 12 hours post dose. Uncertainty regarding the timing of blood sampling and the individual pharmakokinetics for clozapine +/- 2 hours from the 12-hour timepoint, leads to uncertainty regarding the comparability of serum concentrations and the information hold within them. The scope of this trial is to describe changes of s-clozapine and s-N-desmethyl-clozapine within the range of 10-14 hours after the last administration of clozapine . In addition we want to investigate if any of the following covariates might affect the change of s-clozapine and s-N-desmethyl-clozapine: Sex, age, BMI, co-medications, signs of infection, caffeine intake and smoking.

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood samplingblood samples for s-clozapine and s-desmethyl-clozapine analysis are collected at 10, 11, 12, 13 and 14 hours post evening-clozapine-administration
DRUGClozapineRegistration of the exact time of drug administration. Also postponement of any morning clozapine administration until ended blood sampling.

Timeline

Start date
2015-09-01
Primary completion
2015-12-01
Completion
2016-02-01
First posted
2015-12-09
Last updated
2016-02-25

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02625103. Inclusion in this directory is not an endorsement.